COVID-19 drug treatment and risk of death in hospitalized patients in Brazil: a retrospective study of secondary data.
It is suggested that Remdesivir should be considered a preferred option in the treatment of severe cases of COVID-19 in Brazil, supporting the formulation of public health policies.